APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azacitidine Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Azacitidine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchAzacitidine Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Azacitidine Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Azacitidine Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azacitidine Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Azacitidine Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Azacitidine Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azacitidine Injection include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, Eurohealth, Natco Pharma, Shilpa Medicare, Hansoh Pharma, Huiyu Pharmaceutital and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azacitidine Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azacitidine Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azacitidine Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azacitidine Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Azacitidine Injection Segment by Company

Accord Healthcare

Celgene

Dr. Reddy's Laboratories

Eurohealth

Natco Pharma

Shilpa Medicare

Hansoh Pharma

Huiyu Pharmaceutital

Mylan

CTTQ

Azacitidine Injection Segment by Type

50mg

100mg

Azacitidine Injection Segment by Application

Chronic Myelomonocytic Leukemia (CMML)

Acute Myeloid Leukemia (AML)

Higher-risk myelodysplastic syndromes (MDS)

Others

Azacitidine Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azacitidine Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azacitidine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Azacitidine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Azacitidine Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Azacitidine Injection Industry Trends Table 2. Azacitidine Injection Industry Drivers Table 3. Azacitidine Injection Industry Opportunities and Challenges Table 4. Azacitidine Injection Industry Restraints Table 5. Global Azacitidine Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Azacitidine Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Azacitidine Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Azacitidine Injection Sales Market Share by Manufacturers Table 9. Global Azacitidine Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Azacitidine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Azacitidine Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Azacitidine Injection Manufacturers, Product Type & Application Table 13. Global Azacitidine Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Azacitidine Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50mg Table 17. Major Manufacturers of 100mg Table 18. Global Azacitidine Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Azacitidine Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Azacitidine Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Azacitidine Injection Sales Market Share by Type (2021-2026) Table 22. Global Azacitidine Injection Sales Market Share by Type (2027-2032) Table 23. Global Azacitidine Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Azacitidine Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Azacitidine Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Azacitidine Injection Revenue Market Share by Type (2021-2026) Table 27. Global Azacitidine Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Chronic Myelomonocytic Leukemia (CMML) Table 29. Major Manufacturers of Acute Myeloid Leukemia (AML) Table 30. Major Manufacturers of Higher-risk myelodysplastic syndromes (MDS) Table 31. Major Manufacturers of Others Table 32. Global Azacitidine Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Azacitidine Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Azacitidine Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Azacitidine Injection Sales Market Share by Application (2021-2026) Table 36. Global Azacitidine Injection Sales Market Share by Application (2027-2032) Table 37. Global Azacitidine Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Azacitidine Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Azacitidine Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Azacitidine Injection Revenue Market Share by Application (2021-2026) Table 41. Global Azacitidine Injection Revenue Market Share by Application (2027-2032) Table 42. Global Azacitidine Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Azacitidine Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Azacitidine Injection Sales Market Share by Region (2021-2026) Table 45. Global Azacitidine Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Azacitidine Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Azacitidine Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Azacitidine Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Azacitidine Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Azacitidine Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Azacitidine Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Azacitidine Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Azacitidine Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Azacitidine Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Azacitidine Injection Revenue Market Share by Region (2021-2026) Table 63. Global Azacitidine Injection Revenue Market Share by Region (2027-2032) Table 64. Accord Healthcare Company Information Table 65. Accord Healthcare Business Overview Table 66. Accord Healthcare Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Accord Healthcare Azacitidine Injection Product Portfolio Table 68. Accord Healthcare Recent Development Table 69. Celgene Company Information Table 70. Celgene Business Overview Table 71. Celgene Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Celgene Azacitidine Injection Product Portfolio Table 73. Celgene Recent Development Table 74. Dr. Reddy's Laboratories Company Information Table 75. Dr. Reddy's Laboratories Business Overview Table 76. Dr. Reddy's Laboratories Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Dr. Reddy's Laboratories Azacitidine Injection Product Portfolio Table 78. Dr. Reddy's Laboratories Recent Development Table 79. Eurohealth Company Information Table 80. Eurohealth Business Overview Table 81. Eurohealth Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eurohealth Azacitidine Injection Product Portfolio Table 83. Eurohealth Recent Development Table 84. Natco Pharma Company Information Table 85. Natco Pharma Business Overview Table 86. Natco Pharma Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Natco Pharma Azacitidine Injection Product Portfolio Table 88. Natco Pharma Recent Development Table 89. Shilpa Medicare Company Information Table 90. Shilpa Medicare Business Overview Table 91. Shilpa Medicare Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Shilpa Medicare Azacitidine Injection Product Portfolio Table 93. Shilpa Medicare Recent Development Table 94. Hansoh Pharma Company Information Table 95. Hansoh Pharma Business Overview Table 96. Hansoh Pharma Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hansoh Pharma Azacitidine Injection Product Portfolio Table 98. Hansoh Pharma Recent Development Table 99. Huiyu Pharmaceutital Company Information Table 100. Huiyu Pharmaceutital Business Overview Table 101. Huiyu Pharmaceutital Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Huiyu Pharmaceutital Azacitidine Injection Product Portfolio Table 103. Huiyu Pharmaceutital Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Mylan Azacitidine Injection Product Portfolio Table 108. Mylan Recent Development Table 109. CTTQ Company Information Table 110. CTTQ Business Overview Table 111. CTTQ Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. CTTQ Azacitidine Injection Product Portfolio Table 113. CTTQ Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Azacitidine Injection Distributors List Table 117. Azacitidine Injection Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Azacitidine Injection Product Image Figure 2. Global Azacitidine Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azacitidine Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Azacitidine Injection Sales (2021-2032) & (K Units) Figure 5. Global Azacitidine Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Azacitidine Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50mg Image Figure 9. 100mg Image Figure 10. Global Azacitidine Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Azacitidine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Azacitidine Injection Sales Market Share by Type (2021-2032) Figure 13. Global Azacitidine Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Azacitidine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Azacitidine Injection Revenue Market Share by Type (2021-2032) Figure 16. Chronic Myelomonocytic Leukemia (CMML) Image Figure 17. Acute Myeloid Leukemia (AML) Image Figure 18. Higher-risk myelodysplastic syndromes (MDS) Image Figure 19. Others Image Figure 20. Global Azacitidine Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Azacitidine Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Azacitidine Injection Sales Market Share by Application (2021-2032) Figure 23. Global Azacitidine Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Azacitidine Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Azacitidine Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Azacitidine Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Azacitidine Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Azacitidine Injection Sales Market Share by Country (2021-2032) Figure 40. China Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Azacitidine Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Azacitidine Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Azacitidine Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Azacitidine Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Azacitidine Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Azacitidine Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Azacitidine Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Azacitidine Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Azacitidine Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Azacitidine Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Chronic Myelomonocytic Leukemia (CMML)
  • Acute Myeloid Leukemia (AML)
  • Higher-risk myelodysplastic syndromes (MDS)
  • Others
Companies covered
  • Accord Healthcare
  • Celgene
  • Dr. Reddy's Laboratories
  • Eurohealth
  • Natco Pharma
  • Shilpa Medicare
  • Hansoh Pharma
  • Huiyu Pharmaceutital
  • Mylan
  • CTTQ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Azacitidine Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Azacitidine Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Azacitidine Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Azacitidine Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Azacitidine Injection Market Dynamics
  1. 2.1 Azacitidine Injection Industry Trends
  2. 2.2 Azacitidine Injection Industry Drivers
  3. 2.3 Azacitidine Injection Industry Opportunities and Challenges
  4. 2.4 Azacitidine Injection Industry Restraints
3 Azacitidine Injection Market by Manufacturers
  1. 3.1 Global Azacitidine Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Azacitidine Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Azacitidine Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Azacitidine Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azacitidine Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Azacitidine Injection Manufacturers, Product Type & Application
  7. 3.7 Global Azacitidine Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azacitidine Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azacitidine Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azacitidine Injection Tier 1, Tier 2, and Tier 3
4 Azacitidine Injection Market by Type
  1. 4.1 Azacitidine Injection Type Introduction
  2. 4.1.1 50mg
  3. 4.1.2 100mg
  4. 4.2 Global Azacitidine Injection Sales by Type
  5. 4.2.1 Global Azacitidine Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Azacitidine Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Azacitidine Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Azacitidine Injection Revenue by Type
  9. 4.3.1 Global Azacitidine Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Azacitidine Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Azacitidine Injection Revenue Market Share by Type (2021-2032)
5 Azacitidine Injection Market by Application
  1. 5.1 Azacitidine Injection Application Introduction
  2. 5.1.1 Chronic Myelomonocytic Leukemia (CMML)
  3. 5.1.2 Acute Myeloid Leukemia (AML)
  4. 5.1.3 Higher-risk myelodysplastic syndromes (MDS)
  5. 5.1.4 Others
  6. 5.2 Global Azacitidine Injection Sales by Application
  7. 5.2.1 Global Azacitidine Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Azacitidine Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Azacitidine Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Azacitidine Injection Revenue by Application
  11. 5.3.1 Global Azacitidine Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Azacitidine Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Azacitidine Injection Revenue Market Share by Application (2021-2032)
6 Global Azacitidine Injection Sales by Region
  1. 6.1 Global Azacitidine Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azacitidine Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Azacitidine Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Azacitidine Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Azacitidine Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Azacitidine Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Azacitidine Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Azacitidine Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Azacitidine Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Azacitidine Injection Revenue by Region
  1. 7.1 Global Azacitidine Injection Revenue by Region
  2. 7.1.1 Global Azacitidine Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Azacitidine Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Azacitidine Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Azacitidine Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Azacitidine Injection Revenue (2021-2032)
  8. 7.2.2 North America Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Azacitidine Injection Revenue (2021-2032)
  11. 7.3.2 Europe Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Azacitidine Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Azacitidine Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Azacitidine Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Azacitidine Injection Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Celgene
  8. 8.2.1 Celgene Company Information
  9. 8.2.2 Celgene Business Overview
  10. 8.2.3 Celgene Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Celgene Azacitidine Injection Product Portfolio
  12. 8.2.5 Celgene Recent Developments
  13. 8.3 Dr. Reddy's Laboratories
  14. 8.3.1 Dr. Reddy's Laboratories Company Information
  15. 8.3.2 Dr. Reddy's Laboratories Business Overview
  16. 8.3.3 Dr. Reddy's Laboratories Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Dr. Reddy's Laboratories Azacitidine Injection Product Portfolio
  18. 8.3.5 Dr. Reddy's Laboratories Recent Developments
  19. 8.4 Eurohealth
  20. 8.4.1 Eurohealth Company Information
  21. 8.4.2 Eurohealth Business Overview
  22. 8.4.3 Eurohealth Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eurohealth Azacitidine Injection Product Portfolio
  24. 8.4.5 Eurohealth Recent Developments
  25. 8.5 Natco Pharma
  26. 8.5.1 Natco Pharma Company Information
  27. 8.5.2 Natco Pharma Business Overview
  28. 8.5.3 Natco Pharma Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Natco Pharma Azacitidine Injection Product Portfolio
  30. 8.5.5 Natco Pharma Recent Developments
  31. 8.6 Shilpa Medicare
  32. 8.6.1 Shilpa Medicare Company Information
  33. 8.6.2 Shilpa Medicare Business Overview
  34. 8.6.3 Shilpa Medicare Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shilpa Medicare Azacitidine Injection Product Portfolio
  36. 8.6.5 Shilpa Medicare Recent Developments
  37. 8.7 Hansoh Pharma
  38. 8.7.1 Hansoh Pharma Company Information
  39. 8.7.2 Hansoh Pharma Business Overview
  40. 8.7.3 Hansoh Pharma Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hansoh Pharma Azacitidine Injection Product Portfolio
  42. 8.7.5 Hansoh Pharma Recent Developments
  43. 8.8 Huiyu Pharmaceutital
  44. 8.8.1 Huiyu Pharmaceutital Company Information
  45. 8.8.2 Huiyu Pharmaceutital Business Overview
  46. 8.8.3 Huiyu Pharmaceutital Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Huiyu Pharmaceutital Azacitidine Injection Product Portfolio
  48. 8.8.5 Huiyu Pharmaceutital Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Azacitidine Injection Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 CTTQ
  56. 8.10.1 CTTQ Company Information
  57. 8.10.2 CTTQ Business Overview
  58. 8.10.3 CTTQ Azacitidine Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 CTTQ Azacitidine Injection Product Portfolio
  60. 8.10.5 CTTQ Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azacitidine Injection Value Chain Analysis
  2. 9.1.1 Azacitidine Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azacitidine Injection Production Mode & Process
  6. 9.2 Azacitidine Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azacitidine Injection Distributors
  9. 9.2.3 Azacitidine Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst